Drug General Information
Drug ID
D01ZJM
Former ID
DIB015989
Drug Name
R-1479
Synonyms
R1626; 4-Azidocytidine
Drug Type
Small molecular drug
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Discontinued in Phase 1 [547741]
Company
Roche Holding AG
Structure
Download
2D MOL

3D MOL

Formula
C9H12N6O5
Canonical SMILES
C([C@@]1([C@H]([C@H]([C@@H](O1)n1c(=O)nc(cc1)N)O)O)N=[N<br />+]=[N-])O
CAS Number
CAS 478182-28-4
PubChem Compound ID
Target and Pathway
Target(s) RNA polymerase Target Info Inhibitor [527900]
KEGG Pathway Purine metabolism
Pyrimidine metabolism
Metabolic pathways
RNA polymerase
References
Ref 547741Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018944)
Ref 527900The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. J Biol Chem. 2006 Feb 17;281(7):3793-9. Epub 2005 Nov 29.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.